Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions

The role of fluoroquinolones (FQs) as empirical therapy for community-acquired pneumonia (CAP) remains controversial in countries with high tuberculosis (TB) endemicity owing to the possibility of delayed TB diagnosis and treatment and the emergence of FQ resistance in Mycobacterium tuberculosis. Al...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Antimicrob Agents
Main Authors: Shen, Gwan-Han, Tsao, Thomas Chang-Yao, Kao, Shang-Jyh, Lee, Jen-Jyh, Chen, Yen-Hsu, Hsieh, Wei-Chung, Hsu, Gwo-Jong, Hsu, Yen-Tao, Huang, Ching-Tai, Lau, Yeu-Jun, Tsao, Shih-Ming, Hsueh, Po-Ren
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. and the International Society of Chemotherapy. 2012
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7127649/
https://ncbi.nlm.nih.gov/pubmed/22285045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2011.11.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados